Study Evaluating Inotuzumab Ozogamicin (CMC-544) Plus Rituximab In Diffuse Large B-Cell Non-Hodgkin's Lymphoma
Status:
Completed
Trial end date:
2012-10-31
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate inotuzumab ozogamicin in combination with rituximab
prior to an autologous stem cell transplant (aSCT) in patients with relapsed/refractory
diffuse large B-cell Non-Hodgkin's lymphoma.